NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 136 / 982

  1. Revisión y análisis sobre terminologías para drogas psicometabólicas2025 · OpenAlex
  2. Revitalizing Ayurveda with Deep Learning: Automated Identification of Medicinal plants using CNN2025 · Crossref
  3. Reviving industrial hemp in Bangladesh: Opportunity, challenges, and prospects2025 · OpenAlex
  4. Reward and punishment learning among people with a lifetime history of anxiety, depression, and substance use disorder2025 · Crossref
  5. Rewilding ourselves through psychedelic integration2025 · OpenAlex
  6. Rewriting the will: Autonomy and pharmacological desire modification in semaglutide use2025 · Crossref
  7. Rice root aphids, Rhopalosiphum rufiabdominale, and cannabis aphids, Phorodon cannabis (Hemiptera: Aphididae), are parasitised by Aphelinus varipes (Hymenoptera: Aphelinidae)2025 · Crossref
  8. Right Relation with Tobacco: Decommercialization and Reverence2025 · OpenAlex
  9. Rise in alcohol‐linked hepatitis has more adverse impact on women2025 · Crossref
  10. Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns2025 · Crossref
  11. Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings2025 · OpenAlex
  12. Rising transphobia and disparities in drug-related harm experienced by transgender and gender-diverse people2025 · Crossref
  13. Risk communication about high‐dose MDMA: Impact of a hypothetical drug alert on future MDMA use2025 · Crossref
  14. Risk environment influences affecting cocaine market expansion within post-conflict Northern Ireland2025 · OpenAlex
  15. Risk Factors Associated With In-hospital Substance Use Among People Who Use Methamphetamine in London, Ontario2025 · Crossref
  16. Risk Factors for Early-Onset Colorectal Cancer: A Nested Case‒Control Study within the Korean National Health Insurance Service‒Health Screening Cohort2025 · Crossref
  17. Risk Factors for Pancreatic Cancer among Nonsmokers and Nondrinkers of Alcohol in the Women’s Health Initiative2025 · Crossref
  18. Risk management in a global market of alternative addiction care: a case study of the ibogaine medical subculture2025 · OpenAlex
  19. Risk of Relapse Following Discharge from Non-Hospital Residential Opioid Use Disorder Treatment: A Systematic Review of Studies Published from 2018 to 20222025 · OpenAlex
  20. Risk of stroke accompanying alcohol consumption with or without single‐occasion drinking2025 · Crossref
  21. Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study2025 · Crossref
  22. Risk Perceptions Related to Driving After Use of Alcohol and Cannabis in a Cross-National Sample of University Students in 6 Countries2025 · Crossref
  23. Risk, Transgression and Substance Use: An Ethnography of Young British Tourists in Ibiza2025 · OpenAlex
  24. Risks and Effects of Medicinal Plants as an Adjuvant Treatment in Mental Disorders during Pregnancy2025 · Crossref
  25. Risks of Cannabinoid Exposure on Birth Outcomes: A Systematic Review2025 · Crossref
  26. Risks of using psilocybin in treatment of treatment-resistant depression2025 · Crossref
  27. Risky Behaviour after Psychoactive Substance Use2025 · Crossref
  28. Risperidone Induced Ventricular Tachycardia2025 · Crossref
  29. Ritual to Relief: Ethical Frontiers in Repurposing Psychoactive Substances2025 · OpenAlex
  30. Ritual to relief: ethical frontiers in repurposing psychoactive substances.2025 · PubMed
  31. Road Traffic Accidents Epidemiology: Evaluations on a 15 Years Surveillance Program from an Emergency Care Unit (ECU) in Northern Italy2025 · Crossref
  32. Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care2025 · OpenAlex
  33. Robust Detection of Ecstasy‐Like and Adulterants Through ASAP‐MS and DD‐SIMCA2025 · Crossref
  34. Rocking the Boat: Lessons from a Study of the Federal Sentencing of Maritime Drug Traffickers2025 · Crossref
  35. Roland Kuhn—100th Birthday of an Innovator of Clinical Psychopharmacology2025 · Crossref
  36. Role of Asbāb Sitta Ḍarūriyya in the Prevention and Control of Lifestyle Ailments: A Comprehensive Review2025 · Crossref
  37. Role of Cannabis sativa on wound healing: An update2025 · OpenAlex
  38. Role of Community Policing in stopping illegal cultivation of Cannabis: Experiences from Rayagada District in Odisha2025 · Crossref
  39. Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice2025 · OpenAlex
  40. Role of Executive Functions in Substance Use Disorder2025 · OpenAlex
  41. Role of ketamine in the treatment of substance use disorders: A systematic review2025 · OpenAlex
  42. Role of ketamine in treatment-resistant depression2025 · OpenAlex
  43. Role of Law Enforcement in the Reduction of Substance Use and Other Behavioral Health Risks: Substance Use as a Focus: United States as an Example2025 · Crossref
  44. Role of mycelia derived from in vitro cultures of Amanita spp. as a potential source of bioactive compounds with therapeutic potential for the mitigation and management of depressive disorders2025 · Crossref
  45. Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD)2025 · Crossref
  46. Role of Pharmacists in Addiction Medicine in Canada’s Publicly Funded Health Care Systems: A Qualitative Study2025 · Crossref
  47. Role of Phosphorylation of Serotonin and Norepinephrine Transporters in Animal Behavior: Relevance to Neuropsychiatric Disorders.2025 · PubMed
  48. Role of Serotonin in Cadmium Mitigation in Plants2025 · Crossref
  49. Role of trade associations in managing conflict between US cigarette and smokeless tobacco industries2025 · Crossref
  50. Rolling in the green? A closer look at cannabis ETFs’ market munchies2025 · Crossref
  51. Roluperidone monotherapy, a treatment for negative symptoms in schizophrenia2025 · OpenAlex
  52. Rooted Resistance and Vegetal Life in the Poetry of Ana Varela Tafur2025 · OpenAlex
  53. Roots of 20th-Century Western Counterculture: From Guillem Rovirosa’s Catalonia to Its Antipode2025 · Crossref
  54. Root‐Applied Phyto‐Courier Loaded With Rutin Translocates to Aerial Tissues Inducing Molecular and Anatomical Changes in Cannabis sativa Under Salinity2025 · Crossref
  55. Routines Matter: Examining Men’s Experiences of Substance Use Disorder Treatment in a Residential Behavioral Health Facility2025 · Crossref
  56. RSM-Based Optimization of Dose Response and Antibacterial Potential of Cannabis sativa (L.) Leaves Using Computational Analysis2025 · Crossref
  57. RTMS and Addressing Current Challenges in Alcohol and Substance Use Disorder Management2025 · Crossref
  58. Running and Stumbling to Recovery: A Carnal Sociological Study of Change in Substance Use2025 · Crossref
  59. Rural and urban differences in treatment on demand for substance use treatment involving medications for opioid use disorder2025 · Crossref
  60. Rural providers’ attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest2025 · OpenAlex
  61. Rural-Urban Disparities in Inpatient Outcomes for Opioid Overdose: A Nationwide Analysis2025 · Crossref
  62. Rwanda Coffee Export Competitiveness (1990–2024): Time-series Insights into Production, World Prices, Exchange Rates, and Policy Drivers2025 · Crossref
  63. Rx‐to‐OTC Switch, Market Exclusivity, and Consumer Welfare: A Study of the US Anti‐Ulcer Drug Markets2025 · Crossref
  64. Rôle des récepteurs 5-HT4 dans la modulation de la plasticité synaptique au sein du gyrus denté2025 · OpenAlex
  65. S.F. study: Local drug seizures linked to higher overdose risk2025 · Crossref
  66. Saberes da ayahuasca e processos educativos na religião do Santo Daime2025 · OpenAlex
  67. Sabores de lo sagrado: comida, ritual y comunidad en centros budistas de Argentina2025 · Crossref
  68. Sacred smoke and divine vision2025 · OpenAlex
  69. Safer opioid supply clients’ values and preferences: a systematic review and thematic synthesis of qualitative research2025 · OpenAlex
  70. Safer Stimulant Supply: Program Outcomes2025 · OpenAlex
  71. Safety and effectiveness of Donepezil and Memantine in Alzheimer's Disease2025 · Crossref
  72. Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial2025 · OpenAlex
  73. Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: An overview of systematic reviews and meta-analyses2025 · OpenAlex
  74. Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults2025 · OpenAlex
  75. Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder2025 · OpenAlex
  76. Safety considerations for patients using cannabis2025 · Crossref
  77. Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy2025 · OpenAlex
  78. Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis2025 · OpenAlex
  79. Safety, Pharmacokinetics, and Pharmacodynamics of a 6‐h N , N ‐Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled Trial2025 · OpenAlex
  80. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.2025 · PubMed
  81. Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy2025 · Crossref
  82. SALIVARY PH MODULATION WITH BETEL LEAF MOUTHWASH IN SMOKING-RELATED PERIODONTITIS2025 · Crossref
  83. Salivary response of Geoffroy’s spider monkeys (Ateles geoffroyi) to consumption of plant secondary metabolites2025 · Crossref
  84. Salvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential2025 · OpenAlex
  85. Same Story, Different Seller: Teaching the Public How Cannabis Models Driven by Profit Create the Same Injustices as Prohibition2025 · Crossref
  86. SAMHSA on harm reduction vs. overdose reversal drugs2025 · Crossref
  87. SAMHSA warns of benzodiazepine use by older adults2025 · Crossref
  88. Sample size requirements to evaluate policies in addiction research using interrupted time series analysis (ITS): Tools and guidance2025 · Crossref
  89. San Pedro Cactus (Echinopsis pachanoi (Britton & Rose) H. Friedrich & G.D. Rowley Cactceae)2025 · OpenAlex
  90. Sanitary regulation of Cannabis-derived products authorized for importation in Brazil: Characteristics and regulatory trajectory2025 · Crossref
  91. Santé mentale et psychédéliques : révolution ou promesse utopique ?2025 · OpenAlex
  92. SCALE-UP OF THE MANUFACTURING TECHNOLOGY FOR AN IODINE-BASED PHARMACEUTICAL POTENTIATOR WITH ANTIMICROBIAL ACTIVITY2025 · Crossref
  93. Scaling up low barrier wound care for people who use drugs: a mixed methods study2025 · OpenAlex
  94. Scene Empowerment: A Comparative Study of Coca-Cola and PepsiCo’s Scenario-Based Marketing Strategies and Its Implications for Chinese Beverage Companies2025 · Crossref
  95. Schizophrenia and Lung Cancer: Evidence from Mendelian Randomization and Genetic Pleiotropy Analysis2025 · Crossref
  96. Schizophrenia Research: From Epidemiological Trends to Experimental Models, In Vitro Studies, and Emerging Treatments2025 · OpenAlex
  97. Schizophrenia, Psychedelics, and Sense of Self: Comparison of Phenomenology and Neural Correlates2025 · OpenAlex
  98. School Staff Perspectives on Tobacco Prevention: Findings From a Statewide Educator Survey2025 · Crossref
  99. School-based smoking prevention strategies for adolescents in a conservative LMIC context: a qualitative study from Egypt2025 · Crossref
  100. Scientific and Legal Regulation of Measurement of the Non-Medical Drug Use Latency Ratio2025 · Crossref